VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published from Sept 4th-7th; they will resume
distribution on Tuesday, Sept 8th.
|
 |
| September
3, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
James Mackay, Ph.D., President & CEO,
Crystalys Therapeutics |
| In
this Q&A, Mackay discusses the
clinical setback that led him to found
Crystalys, what sets dotinurad apart from
earlier gout therapies, the company's
recent milestones, and where he sees the
company heading over the next three years.
More
|
|
|
 |
|
One Partner For Your Entire
Vivarium. Research Ready From Day
One. |
|
Learn More
→ |
|
|
- Revolution Medicines: New England Journal of
Medicine Publishes Phase 1/2 Clinical Data on
RASONQUE (daraxonrasib) in Metastatic
Non-Small Cell Lung Cancer More
More*
- Ultragenyx: Phase 3 Aspire Results in
Angelman Syndrome More
More
More*
More*
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- LSN: Hot Investor Mandates (Updated 09/01) More
- Olema Oncology: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- Scribe Therapeutics: Second Quarter 2026
Financial Results and Recent Corporate
Highlights More
|
|
- Big4Bio CEO Weekly Q&A: James
Mackay, Ph.D., President & CEO,
Crystalys Therapeutics More
- Biotech & Pharma Updates | September 2,
2026
More
- More on Ultragenyx FDA-Approved Treatment
Showing Sustained Reduction in Cornstarch
Intake More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
- Cellares Details Layoffs as Fast-Growing
Bay Area Company Reacts to Loss of Major
Customer More*
More
- Eikon Therapeutics: Appoints Ching-Pin
Chang, M.D., Ph.D. as Executive Vice
President and Chief Scientific Officer More
- More on ArsenalBio Laying Off 99 Employees
and Shifts Focus to In Vivo CAR-T Programs More
More*
- OPPORTUNITY: Head of Global Research &
Development, Columbia, MD More
- OPPORTUNITY: Head of Marketing &
Communications, Remote More
- OPPORTUNITY: Vice President, Business
Development, Remote More
- Slone Partners: Fractional
Leadership in Biotech and Life Sciences:
When it Works and Why More
- Slone Partners: ICYMI - How to Keep Your
Highest Performers Engaged More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
